Skye Bioscience, Inc. (SKYE)
0.6418
-0.01
(-1.11%)
USD |
NASDAQ |
Mar 23, 16:00
0.6301
-0.01
(-1.82%)
After-Hours: 20:00
Skye Bioscience Accounts Payable (Quarterly) : 2.033M for Dec. 31, 2025
Accounts Payable (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Accounts Payable Definition
Accounting terminology for money that a company owes to vendors for services or products that it purchased on credit. Accounts payable appear on the balance sheet as a current liability.
Accounts Payable (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Accounts Payable (Quarterly) Benchmarks
| Halozyme Therapeutics, Inc. | 20.90M |
| Merck & Co., Inc. | 4.404B |
| SIGA Technologies, Inc. | 0.8245M |
| ACADIA Pharmaceuticals, Inc. | 10.90M |
| Alnylam Pharmaceuticals, Inc. | 115.72M |